308 research outputs found
Protective potential of glucagon like peptide 2 (GLP-2) against the neurodegeneration
Neurodegeneration consists in loss of neuron specific types, pattern and distribution, leading to progressive dysfunctions of the central nervous system. Neurodegenerative diseases include diverse pathological conditions, among which Alzheimer’s and Parkinson’s diseases are the most prevalent ones. Alzheimer’s disease is known as a growing dementia, characterized by progressive language, memory, and cognitive loss, while Parkinson’s disease is primarily characterized as a motor disorder. Senile plaques, caused by amyloid β peptide, hyperphosphorylated tau-based neurofibrillary tangles and synapse loss, are the principal pathological hallmarks of Alzheimer’s disease. Amyloid β oligomer formation is associated with development of reactive oxygen and nitrogen species, inflammation, calcium-dependent excitotoxicity, impairment of cellular respiration, and alteration of synaptic functions related with learning and memory. Parkinson’s disease is produced by dopaminergic neuron deterioration in the extrapyramidal tract of the midbrain. Accumulation of α-synuclein proteins (Lewy bodies) in the central, autonomic, and peripheral nervous system is the hallmark of the Parkinson’s disease. The Levy bodies break the neuronal membrane leading to neuronal death through oxidative stress, excitotoxicity, energy failure and neuroinflammation
Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
The positive role of nutrition in chronic neurodegenerative diseases (NDs) suggests that dietary interventions represent helpful tools for preventing NDs. In particular, diets enriched with natural compounds have become an increasingly attractive, non-invasive, and inexpensive option to support a healthy brain and to potentially treat NDs. Bioactive compounds found in vegetables or microalgae possess special properties able to counteract oxidative stress, which is involved as a triggering factor in neurodegeneration. Here, we briefly review the relevant experimental data on curcuminoids, silymarin, chlorogenic acid, and compounds derived from the microalga Aphanizomenon flos aquae (AFA) which have been demonstrated to possess encouraging beneficial eects on neurodegeneration, in particular on Alzheimer’s disease models
Natural Compounds and Healthy Foods: Useful Tools against Onset and Progression of Chronic Diseases
The Special Issue (SI) in Nutrients, titled “Natural Compounds and Healthy Foods:
New Strategy to Counteract Chronic Diseases”, deals with the beneficial effects of some
natural bioactive substances and the relative action mechanisms, providing evidence for
the potential to counteract some chronic diseases (CD). The Special Issue includes three
reviews and five original articles
GLP-2: What do we know? What are we going to discover?
Glucagon-like peptide 2 [GLP-2] is a 33-amino acid peptide released from themucosal enteroendocrine L-cells of
the intestine. The actions of GLP-2 are transduced by the GLP-2 receptor [GLP-2R], which is localized in the
neurons of the enteric nervous system but not in the intestinal epithelium, indicating an indirect mechanism
of action. GLP-2 is well known for its trophic role within the intestine and interest in GLP-2 is now reviving
based on the approval of the GLP-2R agonist for treatment of short bowel syndrome [SBS]. Recently it also
seems to be involved in glucose homeostasis.
The aimof this reviewis to outline the importance of neuroendocrine peptides, specifically of GLP-2 in the enteric
modulation of the gastrointestinal function and to focus on new works in order to present an innovative picture
of GLP-2
Gastric emptying, small intestinal transit and fecal output in dystrophic (mdx) mice
Duchenne muscular dystrophy (DMD), which results from deficiency in dystrophin, a sarcolemma protein of skeletal, cardiac and smooth muscle, is characterized by progressive striated muscle degeneration, but various gastrointestinal clinical manifestations have been observed. The aim was to evaluate the possible impact of the dystrophin loss on the gastrointestinal propulsion in mdx mice (animal model for DMD). The gastric emptying of a carboxymethyl cellulose/phenol red dye non-nutrient meal was not significantly different at 20 min from gavaging between wild-type and mdx mice. The intestinal transit and the fecal output were significantly decreased in mdx versus normal animals, although the length of the intestine was similar in both animals. The present results provide evidence for motor intestinal alterations in mdx mice in in vivo conditions
Il balcone di Eugenio Montale. Un caso di autocommento indiretto
Durante tutto il corso del suo itinerario poetico, Montale ha sempre tentato di evitare commenti diretti, spiegazioni, che mirassero a sciogliere certa «apparente oscurità» della sua poesia, nata, come affermava lui, da «una estrema concentrazione e da una confidenza forse eccessiva nella materia trattata». Le strategie di rimozione e di depistaggio, in Montale, sono comunissime; basti pensare a quelle che egli ha sempre attuato nei confronti dell’influenza di Eliot, negata categoricamente in più punti della sua saggistica, e all’insofferenza costantemente espressa nei confronti dei questionari di Silvio Guarnieri. In Stile e tradizione, del 1925, si pronunciava contro certi atteggiamenti assoluti e totalitari della critica contemporanea pronta a «pescare nel torbido» e ad «erigere in leggi e in imperativi i nostri estri più incontrollabili». E, ancora, nel 1950, nell’articolo Due sciacalli al guinzaglio, non mancava di polemizzare sulla «troppa luce che i così detti commenti estetici gettano sul mistero della poesia»
Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation
<p>Abstract</p> <p>Background</p> <p>Many natural phenomena are directly or indirectly related to latitude. Living at different latitudes, indeed, has its consequences with being exposed to different climates, diets, light/dark cycles, etc. In humans, one of the best known examples of genetic traits following a latitudinal gradient is skin pigmentation. Nevertheless, also several diseases show latitudinal clinals such as hypertension, cancer, dismetabolic conditions, schizophrenia, Parkinson's disease and many more.</p> <p>Results</p> <p>We investigated, for the first time on a wide genomic scale, the latitude-driven adaptation phenomena. In particular, we selected a set of genes showing signs of latitude-dependent population differentiation. The biological characterization of these genes showed enrichment for neural-related processes. In light of this, we investigated whether genes associated to neuropsychiatric diseases were enriched by Latitude-Related Genes (LRGs). We found a strong enrichment of LRGs in the set of genes associated to schizophrenia. In an attempt to try to explain this possible link between latitude and schizophrenia, we investigated their associations with vitamin D. We found in a set of vitamin D related genes a significant enrichment of both LRGs and of genes involved in schizophrenia.</p> <p>Conclusions</p> <p>Our results suggest a latitude-driven adaptation for both schizophrenia and vitamin D related genes. In addition we confirm, at a molecular level, the link between schizophrenia and vitamin D. Finally, we discuss a model in which schizophrenia is, at least partly, a maladaptive by-product of latitude dependent adaptive changes in vitamin D metabolism.</p
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization
Background: Requests to test for thrombophilia in the clinical context are often not
evidence-based. Aim: To define the role of a series of prothrombotic gene variants in a large
population of patients with different venous thromboembolic diseases. Methods: We studied Factor
V Leiden (FVL), FVR2, FII G20210A, Methylenetetrahydrofolate reductase (MTHFR) C677T and
A1298C, beta-fibrinogen -455 G>A, FXIII V34L, and HPA-1 L33P variants and PAI-1 4G/5G alleles in
343 male and female patients with deep vein thrombosis (DVT), 164 with pulmonary embolism (PE),
126 with superficial vein thrombosis (SVT), 118 with portal vein thrombosis (PVT), 75 with cerebral
vein thrombosis (CVT) and 119 with retinal vein thrombosis (RVT), and compared them with the
corresponding variants and alleles in 430 subjects from the general population. Results: About 40%
of patients with DVT, PE and SVT had at least one prothrombotic gene variant, such as FVL, FVR2
and FII G20210A, and a statistically significant association with the event was found in males with a
history of PE. In patients with a history of PVT or CVT, the FII G20210A variant was more frequent,
particularly in females. In contrast, a poor association was found between RVT and prothrombotic
risk factors, confirming that local vascular factors have a key role in this thrombotic event. Conclusions:
Only FVL, FVR2 and FII G20210A are related to vein thrombotic disease. Other gene variants, often
requested for testing in the clinical context, do not differ significantly between cases and controls.
Evidence of a sex difference for some variants, once confirmed in larger populations, may help to
promote sex-specific prevention of such diseases
A Genotypic-oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macro-categories of Cystic Fibrosis.
Cystic Fibrosis (CF) is a monogenic disease caused by mutations of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene. The genotype-phenotype relationship in this disease is still unclear, and diagnostic, prognostic and therapeutic challenges persist. We enrolled 610 patients with different forms of CF and studied them from a clinical, biochemical, microbiological and genetic point of view. Overall, 125 different mutated alleles (11 of which with novel mutations and 10 of which complex) and 225 genotypes were found. A strong correlation between mutational patterns at the genotypic level and phenotypic macro-categories emerged. This specificity appears to be largely dependent on rare and individual mutations, as well as on the varying prevalence of common alleles in different clinical macro-categories. However, 19 genotypes appeared to underlie different clinical forms of the disease. The dissection of the pathway from the CFTR mutated genotype to the clinical phenotype allowed to identify at least two components of the variability usually found in the genotype - phenotype relationship. One component seems to depend on the genetic variation of CFTR, the other component on the cumulative effect of variations in other genes and cellular pathways independent from CFTR. The experimental dissection of the overall biological CFTR pathway appears to be a powerful approach for a better comprehension of the genotype - phenotype relationship. However, a change from an allele-oriented to a genotypic-oriented view of CFTR genetics is mandatory, as well as a better assessment of sources of variability within the CFTR pathway
- …